Research and Markets
Tinea Pedis Athlete's Foot Therapy Area Pipeline Report - Maintain a Critical Competitive Advantage
Published in Drug Law Weekly, January 5th, 2010
Life Science Analytics, Tinea Pedis (Athletes Foot) Therapy Area Pipeline Report contains detailed information on the tinea pedis (athletes foot) drug pipeline. This report provides insight into the pipeline status of tinea pedis (athletes foot) drugs by company and by stage as well as a summary of the latest news and developments in this area.
Keywords: Dermatomycoses, Health, Other Health, Pharmaceutical, Therapy, Tinea Pedis, Treatment,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2010-01-05)
More Articles from Drug Law Weekly
- Amgen
Amgen Resolves EPO Patent Dispute With Roche - Arrowhead Research Corporation
Arrowhead Announces $3.2 Million Private Placement - AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals Files Registration Statement for Initial Public Offering - Body Weight
Research: Dosage of Morphine for ill Newborns Still too Imprecise - Cannabis Science Inc.
Cannabis Science Begins National Television Educational Series Today With Traders Nation Airing National Tomorrow On CNN, ABC, Fox, CBS Marketwatch, and CNBC, Focusing On Educating Viewers On the GroundDA - Cardiome Pharma Corp.
Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase Plans - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
